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Abstract
The embryonic endoderm is a multipotent progenitor cell population that gives rise to the epithelia
of the digestive and respiratory tracts, the liver and the pancreas. Among the transcription factors
that have been shown to be important for endoderm development and gut morphogenesis is
GATA4. Despite the important role of GATA4 in endoderm development, its transcriptional
regulation is not well understood. In this study, we identified an intronic enhancer from the mouse
Gata4 gene that directs expression to the definitive endoderm in the early embryo. The activity of
this enhancer is initially broad in all endodermal progenitors, as demonstrated by fate mapping
analysis using the Cre/loxP system, but becomes restricted to the dorsal foregut and midgut, and
associated organs such as dorsal pancreas and stomach. The function of the intronic Gata4
enhancer is dependent upon a conserved Forkhead transcription factor-binding site, which is
bound by recombinant FoxA2 in vitro. These studies identify Gata4 as a direct transcriptional
target of FoxA2 in the hierarchy of the transcriptional regulatory network that controls the
development of the definitive endoderm.
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Introduction
During gastrulation, the developing embryo undergoes a precise morphogenetic program
that leads to the establishment of the basic body plan. Just before gastrulation, the amniote
embryo consists of an epithelial layer called the epiblast, which is covered by an
extraembryonic layer, known as the visceral endoderm (Lawson et al., 1986; Tam and
Loebel, 2007). During gastrulation, cells in the epiblast undergo an epithelial-to-
mesenchymal transition, and ingress through the primitive streak (Lawson et al., 1991).
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Ingressing epiblast cells form the mesoderm and endoderm while the embryonic surface
forms the ectoderm. The presumptive definitive endoderm, which gives rise to endodermal
organs, displaces the extraembryonic visceral endoderm, which gives rise to extraembryonic
structures such as the yolk sac (Kadokawa et al., 1987; Weber et al., 1999). The visceral
endoderm shares the expression of many genes with the definitive endoderm (Sherwood et
al., 2007).
After gastrulation, a series of morphogenetic movements transform the definitive endoderm
into a primitive gut tube surrounded by mesoderm. The anterior and posterior regions of the
primitive tube fold ventrally and the tube becomes regionalized along the dorsal-ventral and
anterior-posterior axes into foregut, midgut, and hindgut. These subregions are defined by
specific genetic programs controlled by cell non-autonomous factors derived from nearby
mesoderm and ectodermal tissues and mediated by transcription factors that directly regulate
gene expression in different endoderm-derived organs. (Bort et al., 2004; Grapin-Botton and
Melton, 2000; Kumar et al., 2003; Molotkov et al., 2005; Serls et al., 2005; Stainier, 2002;
Tremblay and Zaret, 2005; Wells and Melton, 2000). The ventral foregut gives rise to the
liver, ventral pancreas, and lungs, while dorsal foregut and anterior regions of the midgut
contribute to the dorsal pancreas, stomach, esophagus, and duodenum. The midgut and
hindgut form the small and large intestines, respectively (Lawson et al., 1986).
Among the transcription factors that have been shown to be crucial for endoderm
development is FoxA2, a member of the Forkhead family of transcription factors (Costa et
al., 1989; Lai et al., 1990). In the early embryo, FoxA2 is expressed in both visceral and
definitive endoderm, the node, the notochord, and the floorplate (Ang et al., 1993;
Monaghan et al., 1993; Ruiz i Altaba et al., 1993; Sasaki and Hogan, 1993). Later in
development, FoxA2 is also present in endoderm-derived tissues, including liver, lung,
stomach, pancreas, small intestine, and colon (Besnard et al., 2004). Targeted disruption of
foxa2 leads to embryonic lethality, and foxa2-null embryos display malformation of the
node, notochord, and foregut endoderm (Ang et al., 1993; Weinstein et al., 1994). Recent
studies, using conditional inactivation approaches, have revealed that FoxA2 is also required
at later stages of development in various endoderm-derived organs (Gao et al., 2008;
Kaestner, 2005; Lantz et al., 2004; Lee et al., 2005; Wan et al., 2004; Zhang et al., 2005).
Mechanistically, FoxA2 functions as a “pioneer factor” by displacing linker histones from
compacted chromatin and facilitating the binding of other transcription factors, including the
zinc finger transcription factor GATA4 (Gualdi et al., 1996; Zaret, 1999; Zaret, 2008; Zaret
et al., 2008).
GATA4 belongs to a family of transcription factors involved in the differentiation of the
endoderm in several evolutionarily diverse organisms (Rehorn et al., 1996; Reiter et al.,
2001; Zhu et al., 1997). Among the members of the GATA family, GATA4 is the first to be
expressed in the visceral and definitive endoderm. GATA4 is also expressed broadly in the
mesoderm of the early mouse embryo (Arceci et al., 1993; Molkentin, 2000). Homozygous
inactivation of Gata4 in mice leads to embryonic lethality, and Gata4-null embryos display
severe defects in the visceral endoderm, malformations in the ventral foregut, and major
disruptions in heart morphogenesis (Kuo et al., 1997; Molkentin et al., 1997), establishing a
crucial role of this transcription factor in these cell lineages. More recently, conditional
inactivation, tetraploid complementation, and mosaic analyses of Gata4 mutant mouse
embryos have also revealed its important role in the differentiation of a variety of
endodermal-derived tissues (Battle et al., 2008; Bosse et al., 2006; Dusing et al., 2001;
Jacobsen et al., 2002; Watt et al., 2007). Similarly, morpholino knockdown experiments
demonstrated a requirement of GATA4 for the proper formation of endodermal organs in the
zebrafish (Holtzinger and Evans, 2005). In addition to its role in differentiation of
endodermal derivatives, GATA4 also appears to participate in endoderm specification in
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cooperation with FoxA2 (Bossard and Zaret, 1998; Cirillo et al., 2002; Zaret, 1999).
However, despite the importance of GATA4 in the development of the early endoderm,
relatively little is known about its transcriptional regulation in vivo.
In this study, we identified a transcriptional enhancer from the mouse Gata4 gene, referred
to as Gata4 G4, which is located in the second intron of the mouse Gata4 gene. Importantly,
this novel intronic enhancer directs expression to the definitive endoderm from early stages
in mouse development. As development proceeds, the activity of the Gata4 G4 enhancer
becomes restricted to cells of the dorsal foregut and midgut. The cells marked by the activity
of this novel Gata4 enhancer at early stages contribute to all endodermal progenitors, as
indicated by Cre-based lineage tracing experiments. Reporter gene expression directed by
the Gata4 G4 enhancer in transgenic embryos in vivo matches the expression of transcripts
for the Forkhead transcription factor FoxA2, and we show the Gata4 G4 enhancer contains
an essential conserved Forkhead binding site that is efficiently bound by recombinant
FoxA2 protein and is required for enhancer activity in vivo. Thus, our studies identify Gata4
as a direct transcriptional target of the Forkhead transcription factor FoxA2 in the early
endoderm and establish a Gata4-expressing progenitor population that contributes to the
entire definitive endoderm.
Materials and Methods
Bioinformatic analyses, cloning, and mutagenesis
Sequence comparisons were performed by using BLAST and VISTA algorithms (Altschul et
al., 1990; Mayor et al., 2000). The 1,107-bp G4 fragment of the mouse Gata4 gene was
generated by PCR from mouse genomic DNA using the following primers: 5′-
tctgcatggaaccaagcttccag-3′ and 5′-ccctgctaactgcagtcatgg-3′. This fragment was then cloned
as a HindIII-PstI fragment into the HindIII-PstI sites of the transgenic reporter plasmid
Hsp68-lacZ (Kothary et al., 1989). The Forkhead site mutant in Gata4 G4 was created by
using primers with the following plus strand sequence: 5′-
attataatcacagactagtcgcagaagtctcaaag-3′. The sequence of the mutant fragment was confirmed
by sequencing on both strands. The Gata4 G4 fragment fused to the Gata4 minimal
promoter containing the mouse Gata4 sequences from −443 to +52, relative to the
transcriptional start site, was cloned into a Cre expression plasmid containing the Cre cDNA
and the SV40 splice and poly A signal sequences to generate plasmid Gata4-G4Gp-Cre. The
GenBank Accession number for the sequence of Gata4 G4 endodermal enhancer is
HM212783.
Generation of transgenic mice
Transgenic lacZ reporter and Cre constructs were digested from their parental plasmid
backbones with SalI, gel purified, and suspended in 5 mM Tris-HCl, 0.2 mM EDTA, pH
7.4, at a concentration of 2 μg/ml for pronuclear injection as described previously (Hogan et
al., 1994). Injected embryos were implanted into pseudopregnant FVB females, and
embryos were collected at indicated times for F0 analysis or were allowed to develop to
adulthood for the establishment of stable transgenic lines. DNA was extracted from the yolk
sac of embryos or from tail biopsies as previously described (Dodou et al., 2003). The
presence of the Gata4-G4-lacZ and Gata4-G4Gp-Cre transgenes were detected by Southern
blot using specific probes for each allele.
X-gal staining, immunohistochemistry, and in situ hybridization
β-galactosidase expression in lacZ transgenic embryos or tissues was detected by X-gal
staining, which was performed as described previously (Dodou et al., 2003). For the analysis
of the Gata4-G4Gp-Cre line, transgenic male founders were crossed with female Rosa26R
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lacZ reporter mice (Soriano, 1999) and embryos were collected at different stages of
development. Transverse and sagittal sections from X-gal stained embryos and tissues were
prepared and counterstained with Neutral Fast Red as described previously (Anderson et al.,
2004). GATA4 immunohistochemistry was performed as previously described (Rojas et al.,
2009). Briefly, dewaxed sections were boiled in antigen retrieval and incubated with 3%
H2O2 for 15 min prior to block with 3% normal goat serum. Incubation with anti-GATA4
antibody (1:300 dilution) was done overnight at 4ºC. Incubation with biotinylated anti-goat
antibody (Vector Laboratories) at a 1:300 dilution was done at room temperature for 1 h.
Immunoperoxidase staining was performed using the Vectastain Elite ABC kit (Vector
Laboratories) and developed using the peroxidase substrate DAB (Vector Laboratories).
Whole mount in situ hybridization was performed as described previously (Rojas et al.,
2005). Following staining, embryos were sectioned at a thickness of 7 μm and
counterstained with Neutral Fast Red for visualization of embryonic structures. foxa2
antisense probe was generated from pBluescript-FoxA2 containing the full-length cDNA
linearized with BamHI, and transcribed using T3 polymerase.
Electrophoretic mobility shift assay (EMSA)
DNA binding reactions were performed as described previously (Dodou et al., 2003). The
foxa2 cDNA was transcribed and translated using the TNT Coupled Transcription-
Translation System (Promega), as described in the manufacturer’s directions. FoxA2 protein
was generated from pcDNA1-FoxA2 plasmid using T7 polymerase. The sense strand
sequence of the mouse Gata4 G4 Forkhead site used for EMSA was: Fox 5′-
gggggttaattataatcacaaataaacgcagaagtctcaaag-3′. The sense strand sequences for the Forkhead
mutant site was the same as for the mutagenic primers described above.
Chromatin Immunprecipitation (ChIP)
ChIP assays were performed using the ChIP assay kit from Upstate Pharmaceuticals
following the recommendations of the manufacturer. Briefly, a 10 cm plate containing
approximately 1×106 AR42J rat cells (Rosewicz et al., 1992), grown in Dulbecco modified
Eagle medium (DMEM) supplemented with 10% fetal bovine serum (FBS), were treated
with 1% paraformaldehyde at 37°C for 10 min to crosslink protein-DNA complexes. Cells
were then lysed and sonicated to shear the DNA into fragments approximately 500 bp in
size. The cleared supernatant was divided into two samples. One of the samples was
incubated with 4 μg of anti-FoxA2 antibody (Santa Cruz Biotechnology) and the other
sample was incubated with 4 μg of anti-rabbit IgG (Santa Cruz Biotechnology) as a
nonspecific control overnight at 4°C. The DNA fragments were then precipitated after
incubating the lysate and antibody mixture with protein A-agarose beads for 1 h. Reactions
were incubated in 200 mM NaCl at 65°C for 4 h to reverse the crosslinks, and DNA was
recovered by phenol-chloroform extraction. The following primers were used to amplify a
fragment of 290 bp encompassing the Gata4 G4 Forkhead site: 5′-
cagttgaattgtcccaaatcagatc-3′ and 5′-ccaactgtggatgaacttagcttcc-3′.
Results
An intronic Gata4 endoderm-specific enhancer directs expression to the dorsal foregut
and midgut in mouse transgenic embryos
Comparison of the Gata4 sequences of mouse, human, and opossum identified nine major
regions of conserved non-coding sequences, referred to as G1–G9 (Fig. 1). Previously, we
demonstrated that two of these conserved regions function as independent, modular
transcriptional enhancers: Gata4 G2 functions as a specific enhancer in lateral mesoderm
and a subset of its derivatives in the liver mesenchyme and Gata4 G8 functions as a late-
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acting endoderm enhancer (Rojas et al., 2005;Rojas et al., 2009). The Gata4 G8 enhancer
directs expression to the foregut and midgut in transgenic mouse embryos, beginning at
embryonic day (E) 9.5 (Rojas et al., 2009), but this enhancer is not active at earlier
embryonic stages when endogenous Gata4 transcripts are already robustly expressed
(Molkentin, 2000;Nemer and Nemer, 2003). Together, these observations suggested that
additional Gata4 endoderm enhancers must exist and prompted us to test additional
conserved sequences from the Gata4 locus for enhancer activity in early transgenic
embryos.
To identify additional Gata4 endoderm enhancers, we cloned each conserved noncoding
region from the Gata4 locus individually into the transgenic reporter plasmid Hsp68-lacZ
(Kothary et al., 1989) and tested for enhancer activity in transgenic mouse embryos. These
analyses indeed resulted in the identification of an additional endoderm-specific enhancer
element, which we refer to as Gata4 G4, with early activity in the visceral and definitive
endoderm (Fig. 1). The Gata4 G4 enhancer element encompasses a conserved region of
1,107 bp, located between exons 2 and 3 (Fig. 1). To evaluate Gata4 G4 activity in vivo, we
generated seven independent transgenic lines harboring the Gata4-G4-lacZ transgene and
analyzed them for β-galactosidase reporter expression during embryonic development. Six
of the transgenic lines showed a consistent lacZ expression pattern in all the embryonic
stages analyzed. We first observed enhancer activity at E7.5 (Fig. 2A). At that stage, Gata4-
G4-lacZ directed expression to the visceral endoderm of the yolk sac, in agreement with the
previously described early expression of endogenous Gata4 in the extra-embryonic
endoderm (Kuo et al., 1997; Molkentin et al., 1997; Nemer and Nemer, 2003) (Fig. 2A).
Extra-embryonic expression was transient and no longer observed at any developmental
stage after E7.5 (Fig. 4A and data not shown). Later, at E8.5, robust Gata4-G4-lacZ
transgene expression was observed in the primitive gut tube formed by the definitive
endoderm (Fig. 2B–D). By E9.5, β-galactosidase activity was observed in the ventral and
dorsal part of the gut tube, and became clearly restricted to the midgut (Fig. 2E, F, K). In the
foregut, lacZ staining was only observed in the most caudal/posterior regions, indicating that
enhancer activity did not extend more rostrally than the developing liver (Fig. 2H). The
expression of the transgene was completely absent from the mesoderm component of the
gut, demonstrating the endodermal specificity of the Gata4 G4 element in vivo.
To characterize the Gata4 endoderm enhancer in more detail, we compared the expression
pattern directed by the enhancer with the expression pattern of the endodermal transcription
factor FoxA2 (Ang et al., 1993). The expression patterns of the Gata4-G4-lacZ transgene
and foxa2 appeared to be nearly identical in the posterior foregut and midgut (Fig. 2,
compare panels E, F, H, K to panels G, I, L). The expression of the Gata4-G4-lacZ
transgene also partially overlapped the expression of endogenous GATA4 protein in the
posterior foregut and midgut at E9.5 (Fig. 2 compare panels H, K to panels J, M). Thus,
these results indicate that G4 enhancer faithfully recapitulates Gata4 endogenous expression
in the early endoderm in transgenic embryos.
Endogenous GATA4 protein expression was broader than Gata4-G4-lacZ and included
other derivatives of the endoderm and mesoderm, such as the entire foregut and gut
mesenchyme (Fig. 2J, M), consistent with previously published reports (Arceci et al., 1993).
The broader expression of endogenous GATA4 protein relative to Gata4-G4-lacZ was
expected since endogenous GATA4 expression is controlled by multiple independent
enhancers with activity in the gut (Rojas et al., 2005; Rojas et al., 2009), and the Gata4 G4
enhancer controls only a subset of the endogenous pattern of expression. In addition to its
expression in the developing gut endoderm, we also observed Gata4-G4-lacZ expression in
the floor plate (Fig. 2H, K) even though endogenous GATA4 protein was not detectable in
the floor plate by immunohistochemistry (Fig. 2J, M). This discrepancy might reflect the
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absence of additional regulatory sequences in the Gata4 G4 enhancer that normally repress
endogenous Gata4 expression in the floor plate.
Gata4 G4 enhancer activity is restricted to the epithelium of the hind-stomach and dorsal
pancreatic bud
At E11.5, expression directed by the Gata4 G4 enhancer was observed only in a subset of
endoderm-derived organs, the epithelium of the glandular stomach, and the dorsal pancreatic
bud (Fig. 3A–C). By E13.5, transgene activity was restricted to the glandular (hind)
stomach, although at lower levels compared to earlier stages of development and it was
absent in the anterior stomach (Fig. 3D). These results are in agreement with the previously
described expression of endogenous Gata4 in the developing stomach (Jacobsen et al.,
2005). In the dorsal pancreas, only a few cells in the epithelium displayed detectable β-
galactosidase activity at E13.5 (Fig. 3E). No transgene expression was observed in the
mesenchyme surrounding the stomach and pancreas, indicating the specificity of the G4
enhancer to direct expression in the endodermal component of these organs. At later stages
in fetal development, the Gata4-G4-lacZ transgene was no longer active since no β-
galactosidase activity was observed in either the hind stomach epithelium or the pancreas
(Fig. 3F). The decreased expression of the transgene coincides with terminal cell
differentiation and maturation, suggesting that the Gata4 G4 enhancer is active mainly at
early stages of endoderm development.
Gata4-G4-Cre expressing cells and their descendents contribute to all endodermally-
derived organs
The results shown in Figure 2 demonstrated that the Gata4-G4-lacZ transgene was
expressed very early in the definitive endoderm of the mouse embryo but then became
restricted to a subset of endoderm derivatives. However, the broad early activity of the
Gata4 G4 enhancer in the endoderm suggested that the cells initially and transiently marked
by Gata4-G4-lacZ might contribute extensively to organs derived from the definitive
endoderm. Therefore, to investigate the developmental potential of the progenitors marked
by the early activity of the Gata4 G4 enhancer, we generated transgenic mice in which the
expression of Cre recombinase was controlled by the Gata4 G4 enhancer linked to the
minimal promoter region of Gata4. We crossed these mice, referred to as Gata4-G4Gp-Cre,
to Rosa26R lacZ reporter mice, which express β-galactosidase constitutively and indelibly in
a Cre-dependent manner (Soriano, 1999). We compared the Cre-dependent lacZ expression
in these embryos to the lacZ expression directly under the control of the Gata4 G4 enhancer
at different stages of development. As mentioned above, Gata4 G4 enhancer activity in the
yolk sac was transient, rapidly extinguishing after E7.5 (Figs. 2A, 4A). However, in Gata4-
G4Gp-CreTg/0; Rosa26lacZ/+ embryos, β-galactosidase activity was observed in the yolk sac
at all stages of embryonic development (Fig. 4B. and data not shown). These results indicate
that the early activation of the Gata4 G4 enhancer in the visceral endoderm marks all of the
progenitors that will give rise to the extra-embryonic endoderm of the yolk sac. As shown in
Figure 3, at E11.5, the Gata4-G4-lacZ transgene was clearly active in the hind stomach and
pancreatic epithelium (Fig. 3A-C and 4C, E). In Gata4-G4Gp-CreTg/0; Rosa26lacZ/+
embryos, β-galactosidase activity was also observed in the stomach epithelium and
pancreatic bud, but its expression was broader than the expression of the Gata4-G4-lacZ
transgene and was present in the epithelium of other endoderm derivatives, including the
liver, and duodenum (Fig. 4D, F), indicating that these structures are derived from a Gata4-
G4-lacZ-expressing progenitor population.
At E13.5, the Cre-dependent lacZ expression of the Gata4-G4Gp-CreTg/0; Rosa26lacZ/+
embryos was detected throughout the endodermal organs of the gastrointestinal and
respiratory tract, including fore- and hind stomach, esophagus, duodenum, branching
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epithelium of the lung and in both dorsal and ventral pancreases (Fig. 4H, J). By
comparison, the direct activity of the Gata4 G4 enhancer (as measured by Gata4-G4-lacZ
expression) was detectable only in a few cells of the dorsal pancreas and hind stomach and
was completely absent from other endodermal organs, including the lungs and the liver (Fig.
4G, I, K). The β-galactosidase activity in Gata4-G4Gp-CreTg/0; Rosa26lacZ/+ embryos
remained robust at later stages of fetal development and after birth in all endodermal organs,
including the liver and the lungs (Figs. 4L and 5F), indicating that the Gata4 G4-marked
progenitor population stably contributed the majority of cells to all of the endodermal
derivatives in the mouse. The specificity of the Gata4 G4 enhancer for the endoderm was
clearly evident based on the complete absence of contribution of any Gata4-G4Gp-Cre-
marked cells in any organs of mesodermal origin, such as kidney, spleen, and heart (Fig. 5B,
D, F). Likewise, Cre activity was completely absent in the mesenchymal compartment of the
lung (Fig. 4J). Taken together, these results show that the Gata4 G4 enhancer is expressed in
a progenitor cell population, which gives rise to the majority of cells in endoderm-derived
organs.
The Forkhead transcription factor FoxA2 binds to a conserved, consensus Forkhead
binding site in the Gata4 G4 endoderm enhancer
To identify how Gata4 expression is controlled in the early endoderm via the Gata4 G4
enhancer, we analyzed the Gata4 G4 element for evolutionarily conserved sequences that
might serve as potential cis-regulatory elements. These analyses identified a consensus
binding site for Forkhead proteins (Fig. 6A). The presence of a perfect, conserved potential
binding site for Forkhead transcription factors, combined with the overlapping expression
patterns of Gata4-G4-lacZ and foxa2 throughout development (Fig. 2), suggested a potential
direct regulatory relationship between FoxA2 and Gata4 via the Gata4 G4 enhancer through
the conserved Forkhead site in the enhancer. As an initial test of this hypothesis, we
examined the ability of recombinant FoxA2 protein to bind to the Forkhead site in the Gata4
G4 enhancer by Electrophoretic Mobility Shift Assay (EMSA) (Fig. 6B). FoxA2 efficiently
bound to the Gata4 G4 Fox site (Fig. 6B, lane 8). Binding was specific because it was
competed by excess unlabeled control Forkhead site site (Fig. 6B, lane 9) and by excess
unlabeled Gata4 G4 Forkhead site (Fig. 6B, lane10), but not by excess unlabeled mutant
versions of either Forkhead site (Fig. 6B, lanes 11, 12). To examine the binding of FoxA2 to
the Gata4 G4 enhancer in more detail, we determined the ability of the Gata4 G4 Forkhead
site and the mutant version of this site to compete for FoxA2 binding to a bona fide control
Fox site. Binding of FoxA2 to the control site was abolished by the addition of unlabeled
Gata4 G4 Forkhead site but was not affected by the addition of an excess of mutant version
of the Gata4 G4 Forkhead site (Fig. 6B, lanes 4, 6).
To investigate whether the Gata4 G4 Forkhead site is occupied by FoxA2 in cells of
endodermal origin, we performed chromatin immunoprecipitation (ChIP) assays in cells of
the AR42J pancreatic cell line (Fig. 6C). The AR42J cell line was derived from a
chemically-induced rat exocrine pancreatic tumor and expresses numerous endodermal
pancreatic transcription factors, including GATA4 and FoxA2 (Aldibbiat et al., 2008;Decker
et al., 2006;Rosewicz et al., 1992). Importantly, the DNA fragment encompassing the
Forkhead site in the endogenous Gata4 G4 enhancer was precipitated and amplified by PCR
when anti-FoxA2 antibody was added to the reaction but not when non-specific IgG was
used for ChIP (Fig. 6C). These results demonstrate that endogenous FoxA2 binds to the
Forkhead site in the endogenous Gata4 G4 enhancer in its normal chromatin context in
endodermally-derived cells. Taken together with the results of the EMSA shown in Fig. 6B,
these results establish the Forkhead site in the Gata4 G4 enhancer as a FoxA2 binding site,
supporting the notion that Gata4 is a direct transcriptional target of FoxA2 via the Gata4 G4
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enhancer. Direct regulation of Gata4 by FoxA2 would be consistent with the overlapping
expression of Gata4-G4-lacZ and foxa2 (Fig. 2).
Gata4 G4 endoderm enhancer activity is dependent on Forkhead-binding site in vivo
To determine the requirement for Forkhead transcription factor binding to the Gata4 G4
enhancer for function in vivo, we introduced mutations identical to those used in EMSA to
completely abolish FoxA2 binding to the site in vitro (Fig. 6B). We then generated
transgenic mice harboring the Gata4-G4-lacZ mutant version and determined the effect of
the Fox site mutation on enhancer activity compared to the wild type Gata4-G4-lacZ
construct at E8.5 (Fig. 7). As in the results shown in Fig. 2, robust expression of the wild
type Gata4-G4-lacZ transgene was observed in the definitive endoderm (Fig. 7A, C). In
sharp contrast, mutation of the Forkhead binding site in the Gata4 G4 enhancer completely
eliminated transgene expression in all three independently generated transgenic lines
examined (Fig. 7B, D), indicating a critical role for Forkhead transcription factor binding,
likely FoxA2, in the activation of the enhancer. Taken together, the coexpression data
showing near precise overlap of the expression of foxa2 and Gata4-G4-lacZ (Fig. 2), the
strong binding of FoxA2 protein to the perfect consensus Forkhead site in the enhancer (Fig.
6), and the absolute requirement of the Fox site for enhancer function in vivo, strongly
support a pathway in which FoxA2 is a direct transcriptional activator of Gata4 in the early
endoderm via the enhancer identified and described in these studies.
Discussion
Dynamic expression and modular regulation of Gata4 during endoderm development
The Gata4 G4 enhancer described here directs robust expression to the endoderm in the
early developing mouse embryo. The activity of this enhancer becomes restricted at
midgestation to a small subset of endodermal derivatives in the dorsal foregut and midgut
that will form the dorsal pancreas and stomach. Our Cre-based fate mapping experiments
show that the total temporal and spatial activity of the Gata4 G4 enhancer from its initial
activation broadly in the endoderm at early times to its more restricted activity later results
in the marking of all definitive endodermal derivatives from both ventral and dorsal foregut,
midgut, and hindgut. When this broad contribution of Cre-marked cells is compared to the
very restricted expression of the Gata4-G4-lacZ transgene at later stages of development,
the results suggest that that the Gata4-G4 positive cells represent a pool of early multipotent
endodermal progenitors, and while the activity of the enhancer itself is extinguished, the
cells marked by the enhancer at early stages ultimately contribute to essentially all
endodermally-derived cells in the embryo. However, we cannot formally exclude a very
transient expression of the Gata4-G4 enhancer in other gut domains at later stages that may
account for the further contribution of Gata4-G4 positive cells to all endodermal derivatives.
We have recently described another Gata4 endoderm enhancer, referred to as Gata4 G8
(Rojas et al., 2009). Interestingly, the Gata4 G8 enhancer directs expression to the visceral
and definitive endoderm at later stages of development than the Gata4 G4 enhancer
described in the present studies. The previously described Gata4 G8 enhancer is active in
the primitive gut tube and yolk sac beginning at E9.5. In contrast to the Gata4 G4 enhancer
described here, the previously described Gata4 G8 enhancer remains active at later stages of
development, although its activity also becomes restricted to pancreas, stomach and
duodenum and yolk sac (Rojas et al., 2009).
The existence of two endoderm-specific enhancers in the Gata4 gene might be related to the
multiple roles of this transcription factor in endoderm development and, more specifically,
in the development of pancreas and stomach. Alternatively, the two enhancers might
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represent temporally discrete transcriptional units with the early Gata4 G4 enhancer serving
as an initiation element and the later Gata4 G8 enhancer serving as a maintenance unit. This
type of model would be consistent with previously described examples of transcriptional
control in the endoderm and other lineages where multiple enhancers differentially regulate
initial activation versus maintenance of gene expression (Chen and Goldhamer, 2004;
Meredith et al., 2009; Sasaki and Hogan, 1996; Teboul et al., 2002). It is interesting that the
activities of Gata4 G4 and Gata4 G8 enhancers overlap at E9.5 in the dorsal foregut and
midgut, a key period in endoderm development when organ buds start to form. The selective
advantage of the modularity is not well understood, but perhaps it serves to fine tune the
spatiotemporal and quantitative control of Gata4 expression and the subsequent
transcriptional programs downstream of this key transcription factor gene.
The rapid and progressive restriction of the Gata4 G4 enhancer activity from E7.5 to E11.5
suggests that the activators of the enhancer might also become restricted during
development. Alternatively, the enhancer may contain specific sites for repressors that
inhibit enhancer activation in other tissues. One of the most intriguing aspects of the
expression pattern directed by the Gata4 G4 enhancer is the exclusive localization to the
caudal foregut and midgut region of the gut tube at later times in its activity. It is well
known that the developing endoderm displays clear anterior-posterior patterning influenced
by signals from the adjacent germ layers that act in a graded manner (Kumar et al., 2003).
These signals are critical for the proper development of the gut tube. The specific expression
pattern directed by the Gata4 G4 enhancer suggests that it may respond to different
thresholds of mesodermal signals that restrict its activity in the precise anterior-posterior
pattern observed in the present studies.
A transcriptional regulatory network for endoderm development by GATA4 and FoxA2
GATA and Forkhead transcription factors are involved in the specification and
differentiation of different endodermal cell types in different organisms, including the fly,
the nematode, the mouse, and the fish (Dufort et al., 1998; Fukushige et al., 1998; Mango et
al., 1994; Narita et al., 1997; Reiter et al., 2001; Weigel et al., 1989; Zhu et al., 1997).
GATA4 and FoxA2 are among the earliest transcription factors to be expressed in the
embryonic endoderm in the mouse, and they synergistically activate the expression of
endoderm-specific genes (Cirillo et al., 2002; Denson et al., 2000). In this study, we
demonstrate that the Gata4 G4 endoderm enhancer requires a conserved Forkhead binding
site for function in vivo. Based on the overlapping expression pattern of foxa2 and Gata4-
G4-lacZ transgene and the efficient binding of FoxA2 to the Forkhead site in the Gata4 G4
enhancer in vitro and in vivo (Figs. 2, 5), our studies strongly support a role for FoxA2 as a
direct transcriptional regulator of Gata4 in the early endoderm.
It would be interesting to determine if the direct regulatory relationship between GATA4
and FoxA2 is reciprocal, since it has been shown in other organisms that GATA factors are
likely direct regulators of Forkhead genes. For example, the Drosophila GATA4 ortholog
Serpent influences the expression of forkhead in the midgut (Casanova, 1990; Reuter, 1994).
Similarly, the promoter of PHA-4, the C. elegans FoxA2 ortholog, is bound and
transactivated by two different GATA factors, ELT-1 and ELT-2, in the worm (Azzaria et
al., 1996; Horner et al., 1998; Kalb et al., 1998). The reciprocal activation of Gata4 and
FoxA2 could serve to reinforce in a feed-forward fashion a regulatory circuit designated to
amplify a transcriptional response for specification and differentiation of different
endodermal organs.
A mechanism by which FoxA2 and GATA4 might function together in multipotent
endoderm cells has been described previously. GATA4 and FoxA2 serve as pioneer factors
for the induction of endoderm gene expression, and they were shown to bind to the
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chromatin of the silent Alb gene in the endoderm prior to the hepatic induction (Bossard and
Zaret, 1998; Cirillo et al., 1998; Zaret, 1999). Upon inductive and permissive signals, the
two transcription factors relax the compacted chromatin, allowing the binding of other
transcription factors to activate the transcription of Alb and other genes to initiate the liver
program (Bossard and Zaret, 1998; Cirillo et al., 2002). Our studies, described here, support
a feed forward model for endoderm specification in which FoxA2 directly activates the
expression of its own transcriptional partner GATA4. It will be interesting to determine
whether this mechanism involving GATA4 and FoxA2 represents a general mechanism by
which endoderm competence is predermined. Genome-wide analyses of FoxA2 and GATA4
bound to their targets in multipotent endodermal cells will provide new insights into how
cell specification is achieved along the gut tube.
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Fig. 1.
A schematic representation of the mouse Gata4 locus and the Gata4-G4-lacZ transgene. The
mouse Gata4 locus, including the seven Gata4 exons (vertical lines) and the transcriptional
start site (bent arrow) is depicted in the top schematic. Conserved non-coding regions among
the human, mouse and opossum Gata4 sequences are represented as red boxes (G1–G9).
The lower schematic depicts the Gata4 G4 intronic sequences cloned into the reporter vector
HSP68-lacZ.
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Fig. 2.
The Gata4-G4-lacZ transgene is expressed in the visceral and definitive endoderm, dorsal
foregut, midgut, and derivatives of the definitive endoderm in the developing stomach and
pancreas during mouse embryonic development. Whole mount (A, B, E), sagittal (C, F) and
transverse (D, H, K) sections of X-gal stained Gata4-G4-lacZ transgenic embryos are
shown. For comparison, whole mount (G) and transverse (I, L) sections of foxa2 in situ
hybridization and transverse sections (J, M) of GATA4 immunohistochemistry are shown.
White arrowheads mark the definitive endoderm. Transgene expression was only detected
transiently in the visceral endoderm of the yolk sac (ys) at E7.5 (A). At slightly later stages,
Gata4-G4-lacZ expression appeared in the definitive endoderm (B–D). By E9.5, lacZ
expression became restricted to the caudal foregut (fg) and midgut (mg) where expression
mirrored the expression of the endodermal marker foxa2 (G, I, L) and endogenous GATA4
(J, M) but was absent in the anterior foregut (black arrows). Bars in all panels=100μm. h,
heart; st, septum transversum.
Rojas et al. Page 16
Dev Biol. Author manuscript; available in PMC 2011 October 15.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Fig. 3.
Expression directed by the Gata4-G4-lacZ transgene becomes restricted to the stomach
epithelium and dorsal pancreatic bud. Whole mount (A) and sagittal sections (B–F) of X-
gal-stained Gata4-G4-lacZ transgenic embryos are shown. At E11.5, X-gal staining was
observed in the nascent epithelium of the hind stomach and in the pancreatic epithelium (A–
C). By E13.5, transgene activity began to diminish in both the hind stomach (arrowhead in
D) and the pancreas epithelium (pan epi) (E). No transgene expression was observed at
E16.5 (F). Arrow marks the anterior stomach and asterik indicates the stomach mesenchyme
in D. (sto) stomach; (eso) esophagus; (duo) duodenum; (pan) pancreas; (pan m) pancreas
mesenchyme (li), liver.
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Fig. 4.
The Gata4 G4 enhancer is active in all endodermal progenitors in the mouse embryo. Yolk
sac (A, B), sagittal (C, D) and transverse (E, F) sections and dissected organs (G–L)
collected from either Gata4-G4-lacZ (A, C, E, G, I, K) or Gata4-G4Gp-CreTg/0,
Rosa26 lacZ/+ (B, D, F, H, J, L) transgenic embryos were stained for β-galactosidase activity
with X-gal. At E11.5, Gata4-G4-lacZ expression was absent in the yolk sac and detected
only in the epithelium of the hind stomach and pancreas (A, C, E). Gata4-G4Gp-CreTg/0,
Rosa26 lacZ/+ embryos exhibited a similar pattern of lacZ expression in these tissues, but
expression was also apparent in other endoderm-derived including the yolk sac and organs,
such as liver, duodenum(B, D, F), indicating that the Gata4 G4 enhancer was once active in
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the progenitors of these organs at earlier stages. By E13.5, the activity of Gata4-G4-lacZ
transgene activity became weaker and staining was only observed in the dorsal pancreas and
hind-stomach (E). No staining was observed in the lungs of Gata4-G4-lacZ transgenic
embryos (I) at E13.5 or in the liver at E16.5 (K). By contrast, Gata4-G4Gp-CreTg/0,
Rosa26 lacZ/+ embryos exhibited X-gal staining in both dorsal and ventral pancreases, fore-
and hind stomach, duodenum, esophagus, liver, and lungs (H, J, L), indicating that these
structures were derived from an earlier Gata4-G4Gp-Cre-expressing population of cells.
Note the specific X-gal staining of Gata4-G4Gp-CreTg/0, Rosa26 lacZ/+ embryos in the
endoderm compartment of the lung (en) but not in the mesenchymal (m) component (H).
(sto), stomach; (pan), pancreas; (dpan), dorsal pancreas; (vpan), ventral pancreas; (h), heart;
(nt), neural tube; (li), liver; (lu), lungs; (duo), duodenum.
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Fig. 5.
The Gata4 G4 enhancer is not active in the mesoderm or its derivatives at any stage in
development. Representative organs dissected from Gata4-G4-lacZ (A, C, E) and Gata4-
G4Gp-CreTg/0, Rosa26 lacZ/+ (B, D, F) newborn mice (P0) were assayed for β-galactosidase
activity. Gata4-G4Gp-Cre indelibly labeled cells in the lung epithelium of newborn mice
(arrowhead in F), consistent with its activity in the endoderm. At that stage, no direct
expression of the Gata4-G4-lacZ transgene was observed in the lungs (arrowhead E). No
mesodermal organs, including kidney (k) (A, B), spleen (sp) (C, D), or heart (asterisks in E,
F) were labeled in either Gata4-G4-lacZ or Gata4-G4Gp-CreTg/0; Rosa26RlacZ/+ mice.
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Fig. 6.
The Gata4-G4-lacZ transgene contains an evolutionary conserved Forkhead binding site that
is bound by FoxA2 protein in vitro and in vivo. (A) ClustalW analysis of Gata4 G4
sequences from mouse, human, and opossums revealed a highly conserved, perfect
consensus Forkhead binding site (orange box). Asterisks denote nucleotides that have been
perfectly conserved among the three species. (B) Recombinant FoxA2 protein was used in
EMSA with radiolabeled double-stranded oligonucleotide probe representing a canonical
Forkhead binding site from the Gata4 G2 lateral mesoderm enhancer (Rojas et al., 2005)
(lanes 1–6) or the Gata4 G4 Forkhead site (lanes 7–12). Lanes 1 and 7 contain reticulocyte
lysate without recombinant FoxA2 protein. FoxA2 efficiently bound to the Forkhead control
site and to the Gata4 G4 Forkhead site (lanes 2, 8). In both cases, binding was competed by
excess, unlabeled control Forkhead site (C, lanes 3 and 9) or unlabeled Gata4 G4 Forkhead
site (G4, lanes 4 and 10), but not by excess unlabeled mutant control (mC, lanes 5 and 11) or
an unlabeled mutant version of the Gata4 G4 (M, lanes 6 and 12) Forkhead sites. (C) FoxA2
binds to the endogenous Gata4 G4 enhancer in vivo. AR42J pancreatic cells were subjected
to ChIP to detect endogenous FoxA2 bound to the Gata4 G4 enhancer using anti-FoxA2
antibody. Following ChIP, the Gata4 G4 Forkhead site was detected using specific primers
flanking the Gata4 G4 Fox binding site. PCR products were analyzed by agarose gel
electrophoresis. Lane 2 contains PCR product obtained following ChIP using anti-FoxA2
antibody (α-Fox). Lane 3 contains PCR product obtained following ChIP using a non-
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specific anti-IgG (α-IgG). Lane 1 contains PCR product from input (Inp) amplified prior to
immunoprecipitation. Sizes in bp are shown at the left.
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Fig. 7.
The Gata4 G4 early endoderm enhancer is dependent on its conserved Forkhead (Fox) site
for activity in vivo. Wild type and mutant versions of the Gata4-G4-lacZ transgene were
used to generate transgenic embryos. Lateral (A, B) and frontal view (C, D) of X-gal stained
transgenic embryos at E8.5 are shown. The wild type construct reproducibly directed
expression to the definitive endoderm (A, C). Mutation of the Gata4 G4 Forkhead site
completely abolished transgene expression in each of three independently-generated F0
transgenic embryos analyzed (B, D). Arrowheads mark the definitive endoderm in all four
panels.
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